Frequent Dose of Peginterferon Alfa 2a Evaluation in Treatment-Naïve Chronic HCV,Genotype 4 Egyptian Patients

2014 ◽  
Vol 57 ◽  
pp. 431-436
Author(s):  
Shendy Mohammed Shendy ◽  
Abdel Aziz Ali Saleem ◽  
Mohamed Darwish El-Talkawy ◽  
Ayman AbdelAziz
Keyword(s):  
Genotype 4 ◽  
Hcv Genotype ◽  
Frequent Dose ◽  
Egyptian Patients ◽  
Treatment Naïve ◽  
Chronic Hcv ◽  
Peginterferon Alfa

Insulin resistance: a predictor for response to interferon-based therapy in Egyptian patients with chronic HCV genotype 4

2012 ◽  
Vol 23 (1) ◽  
pp. 7-13
Author(s):  
Sherif Mogawer ◽  
Mona Mansour ◽  
Mohamed Marie ◽  
Mervat El-Ansary ◽  
Samah Abd El-Hamid
Keyword(s):  
Insulin Resistance ◽  
Genotype 4 ◽  
Hcv Genotype ◽  
Egyptian Patients ◽  
Chronic Hcv

763 All-Oral Therapy With Daclatasvir in Combination With Asunaprevir and Bms-791325 for Treatment-Naive Patients With Chronic HCV Genotype 4 Infection

2014 ◽  
Vol 146 (5) ◽  
pp. S-926
Author(s):  
Tarek Hassanein ◽  
Gregory T. Everson ◽  
Karen Sims ◽  
Michael T. Bennett ◽  
Norman Gitlin ◽  
...  
Keyword(s):  
Oral Therapy ◽  
Genotype 4 ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Chronic Hcv

scholarly journals 819Daclatasvir in Combination with Peginterferon Alfa-2a and Ribavirin for Treatment-Naive Patients with HCV Genotype 4 Infection: Phase 3 COMMAND-4 Results

2014 ◽  
Vol 1 (suppl_1) ◽  
pp. S233-S233 ◽  
Author(s):  
Christophe Hézode ◽  
Laurent Alric ◽  
Ashley Brown ◽  
Tarek Hassanein ◽  
Mario Rizzetto ◽  
...  
Keyword(s):  
Phase 3 ◽  
Genotype 4 ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Peginterferon Alfa
Sign in / Sign up

Export Citation Format

Share Document